Detalhe da pesquisa
1.
The clinical management and outcomes of cervical neuroblastic tumors.
J Surg Res
; 204(1): 109-13, 2016 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27451875
2.
Oxaliplatin and Doxorubicin for relapsed or refractory high-risk neuroblastoma.
Pediatr Hematol Oncol
; 32(1): 26-31, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25551355
3.
Pilot study assessing a seven-day continuous intrathecal topotecan infusion for recurrent or progressive leptomeningeal metastatic cancer.
J Oncol Pharm Pract
; 20(3): 229-32, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23929729
4.
Lenalidomide overcomes suppression of human natural killer cell anti-tumor functions by neuroblastoma microenvironment-associated IL-6 and TGFß1.
Cancer Immunol Immunother
; 62(10): 1637-48, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-23982484
5.
Continuous and bolus intraventricular topotecan prolong survival in a mouse model of leptomeningeal medulloblastoma.
PLoS One
; 14(1): e0206394, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30608927
6.
TGFßR1 Blockade with Galunisertib (LY2157299) Enhances Anti-Neuroblastoma Activity of the Anti-GD2 Antibody Dinutuximab (ch14.18) with Natural Killer Cells.
Clin Cancer Res
; 23(3): 804-813, 2017 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27756784
7.
Expression of Five Neuroblastoma Genes in Bone Marrow or Blood of Patients with Relapsed/Refractory Neuroblastoma Provides a New Biomarker for Disease and Prognosis.
Clin Cancer Res
; 23(18): 5374-5383, 2017 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28559462